Associations between Sleep Quality and Serum Levels of Neurofilament Light in Individuals with Premanifest Huntington Disease

被引:0
|
作者
Turner, Mitchell [1 ,2 ]
Bartlett, Danielle [2 ]
Poudel, Govinda [3 ]
Zaenker, Pauline [1 ,2 ]
Laws, Simon [1 ,2 ]
Lo, Johnny [4 ]
Ziman, Mel [2 ]
Cruickshank, Travis [1 ,2 ,5 ]
机构
[1] Edith Cowan Univ, Ctr Precis Hlth, Perth, WA 6027, Australia
[2] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia
[3] Australian Catholic Univ, Mary Mackillop Inst Hlth Res, Melbourne, Vic, Australia
[4] Edith Cowan Univ, Sch Sci, Perth, WA, Australia
[5] Perron Inst Neurol & Translat Sci, Perth, WA, Australia
关键词
sleep quality; Huntington disease; neurofilament proteins;
D O I
10.1055/s-0043-1777783
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives To evaluate the associations between sleep quality and serum levels of neurofilament light (NfL) protein in individuals with premanifest Huntington disease (HD). Materials and Methods We recruited 28 individuals with premanifest HD from a pre-existing database (of the Huntington's Environmental Research Optimisation Scheme, HEROs). The participants filled out the Pittsburgh Sleep Quality Index (PSQI), a subjective measure of sleep quality, and blood was collected via routine venepuncture to measure peripheral NfL levels. Results The PSQI scores (median: 5.0; interquartile range: 4.0-7.5) indicated poor sleep quality. General linear modelling revealed no significant ( p = 0.242) association between PSQI scores and NfL levels. No significant differences were found between individuals with good and poor sleep quality for any demographic variable collected. Discussion Contrary to studies on other neurological conditions, there was no association between sleep quality and NfL levels in individuals with premanifest HD. This was unexpected, given the influence of environmental factors (such as social network size) on neurodegeneration in individuals with premanifest HD.
引用
收藏
页码:e199 / e202
页数:4
相关论文
共 50 条
  • [31] Parallel evaluation of mutant huntingtin and neurofilament light in Huntington's disease
    Byrne, L.
    Rodrigues, F.
    Johnson, E.
    De Vita, E.
    Czech, C.
    Schobel, S.
    Scahill, R.
    Heslegrave, A.
    Zetterberg, H.
    Wild, W.
    MOVEMENT DISORDERS, 2018, 33 : S370 - S374
  • [32] Neurofilament light protein in blood predicts regional atrophy in Huntington disease
    Johnson, Eileanoir B.
    Byrne, Lauren M.
    Gregory, Sarah
    Rodrigues, Filipe B.
    Blennow, Kaj
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A.
    Zetterberg, Henrik
    Tabrizi, Sarah J.
    Scahill, Rachael I.
    Wild, Edward J.
    NEUROLOGY, 2018, 90 (08) : E717 - E723
  • [33] Neurofilament Light Protein in Blood as a Biomarker of Neurodegeneration in Huntington's Disease
    Wild, Edward J.
    Byrne, Lauren M.
    Rodrigues, Filipe B.
    Blennow, Kaj
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A. C.
    Scahill, Rachael I.
    Tabrizi, Sarah J.
    Zetterberg, Henrik
    Langbehn, Douglas
    ANNALS OF NEUROLOGY, 2017, 82 : S187 - S187
  • [34] Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington's disease
    Sampedro, Frederic
    Martinez-Horta, Saul
    Perez-Perez, Jesus
    Perez-Gonzalez, Rocio
    Horta-Barba, Andrea
    Campolongo, Antonia
    Aracil-Bolanos, Ignacio
    Gomez-Anson, Beatriz
    Kulisevsky, Jaume
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (12): : 2309 - 2313
  • [35] Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers
    Novobilsky, Richard
    Bartova, Petra
    Licha, Karin
    Bar, Michal
    Stejskal, David
    Kusnierova, Pavlina
    FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
  • [36] Associations of Serum Neurofilament Light Chain with Outcomes in Children with Autoimmune Encephalitis
    Da Silva, Susana
    Yea, Carmen
    Madani, Jihan
    Wagner, Matt
    Longoni, Giulia
    Branson, Helen M.
    Vidarsson, Logi
    Ertl-Wagner, Birgit
    Yeh, E. Ann
    NEUROLOGY, 2023, 100 (17)
  • [37] The effects of multidisciplinary rehabilitation on neuroimaging, biological, cognitive and motor outcomes in individuals with premanifest Huntington's disease
    Bartlett, Danielle M.
    Govus, Andrew
    Rankin, Timothy
    Lampit, Amit
    Feindel, Kirk
    Poudel, Govinda
    Teo, Wei-Peng
    Lo, Johnny
    Georgiou-Karistianis, Nellie
    Ziman, Mel R.
    Cruickshank, Travis M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 416
  • [38] Associations of Longitudinal Serum Neurofilament Light Chain Levels with Clinico-Radiological Outcomes in the MS PATHS Network
    Sotirchos, Elias
    Fitzgerald, Kathryn
    Singh, Carol
    Smith, Matthew
    Reyes-Mantilla, Maria
    Arrambide, Georgina
    Fernandez, Victoria
    Montalban, Xavier
    Comabella, Manuel
    Hersh, Carrie
    Hyland, Megan
    Naismith, Robert
    Qiao, Min
    Krupp, Lauren
    Nicholas, Jacqueline
    Akguen, Katja
    Ziemssen, Tjalf
    Lambe, Jeffrey
    Bermel, Robert
    Mowry, Ellen
    Calabresi, Peter
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 60 - 61
  • [39] Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study
    Jakimovski, Dejan
    Kuhle, Jens
    Ramanathan, Murali
    Barro, Christian
    Tomic, Davorka
    Hagemeier, Jesper
    Kropshofer, Harald
    Bergsland, Niels
    Leppert, David
    Dwyer, Michael G.
    Michalak, Zuzanna
    Benedict, Ralph H. B.
    Weinstock-Guttman, Bianca
    Zivadinov, Robert
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (09): : 1757 - 1770
  • [40] Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression
    Parkin, Georgia M.
    Corey-Bloom, Jody
    Snell, Chase
    Castleton, Jordan
    Thomas, Elizabeth A.
    PARKINSONISM & RELATED DISORDERS, 2021, 87 : 32 - 38